Skip to main content

Advertisement

SpringerLink
Log in

Estrogen receptor beta exerts growth-inhibitory effects on human mammary epithelial cells

  • Preclinical study
  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

Abstract

Estrogen receptor β (ERβ) is widely expressed in mammary epithelium. ERβ expression is reported to decline during carcinogenesis of the breast and other tissues. In this study, we examined the consequences of a loss of ERβ expression in mammary epithelial cells. We knocked down ERβ transcript levels in human mammary epithelial MCF-10A cells and in MCF-7 breast cancer cells by means of stable transfection with a specific shRNA plasmid. ERβ knockdown resulted in a significant growth increase of both cell types in a ligand-independent manner. This effect was accompanied by elevated cyclin A2 expression in MCF-10A cells and by decreased expression of growth-inhibitory p21/WAF and epithelial cell marker cytokeratine 8 in both cell lines. Transfection of ERβ shRNA did not alter the absent proliferative estrogen response of MCF-10A cells, but conferred sensitivity to selective estrogen receptor modulator tamoxifen to this cell line. In contrast, ERβ knockdown diminished estrogen responsiveness of MCF-7 breast cancer cells and also weakened the effect of tamoxifen on this cell line. These ligand-dependent effects only observed in MCF-7 cells exhibiting a high ERα/β ratio were accompanied by smaller estrogenic repression of p21/WAF expression, an impaired tamoxifen-triggered induction of this gene and by relative downregulation of ERα and cyclin A2 transcript levels. Our data suggest that ERβ exerts antiproliferative effects both on MCF-10A and MCF-7 cells in a ligand- and ERα-independent manner by regulation of p21/WAF or cyclin A2 gene expression. Knockdown of ERβ in both cell types was sufficient to significantly decrease transcript levels of epithelial cell marker cytokeratin 8. The results of this study support the hypothesis that ERβ acts as a tumor suppressor in mammary epithelium.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Ali S, Coombes RC (2002) Endocrine-responsive breast cancer and strategies for combating resistance. Nat Rev Cancer 2(2):101–112. doi:10.1038/nrc721

    Article  PubMed  Google Scholar 

  2. Kuiper GG, Enmark E, Pelto-Huikko M, Nilsson S, Gustafsson J-A (1996) Cloning of a novel receptor expressed in rat prostate and ovary. Proc Natl Acad Sci USA 93(12):5925–5930. doi:10.1073/pnas.93.12.5925

    Article  CAS  PubMed  Google Scholar 

  3. Leygue E, Dotzlaw H, Watson P, Murphy L (1998) Altered estrogen receptor alpha and beta mRNA expression during human breast tumorigenesis. Cancer Res 58:3197–3201

    CAS  PubMed  Google Scholar 

  4. Jarvinen T, Pelto-Huikko M, Holli K, Isola J (2000) Estrogen receptor beta is coexpressed with ERalpha and PR and associated with nodal status grade and proliferation rate in breast cancer. Am J Pathol 156:29–35

    CAS  PubMed  Google Scholar 

  5. Forster C, Makela S, Warri A, Kietz S, Becker D, Hultenby K, Warner M, Gustafsson J (2002) Involvement of estrogen receptor b in terminal differentiation of mammary gland epithelium. Proc Natl Acad Sci USA 99:15578–15583. doi:10.1073/pnas.192561299

    Article  CAS  PubMed  Google Scholar 

  6. Hall J, McDonnell D (1999) The estrogen receptor betaisoform (ERbeta) of the human estrogen receptor modulates ERalpha transcriptional activity and is a key regulator of the cellular response to estrogens and antiestrogens. Endocrinology 140:5566–5578. doi:10.1210/en.140.12.5566

    Article  CAS  PubMed  Google Scholar 

  7. Weihua Z, Saji S, Makinen S, Cheng G, Jensen E, Warner M, Gustaffson JA (2000) Estrogen receptor (ER) b a modulator of ERa in the uterus. Proc Natl Acad Sci USA 97:5936–5941. doi:10.1073/pnas.97.11.5936

    Article  CAS  PubMed  Google Scholar 

  8. Peng B, Lu B, Leygue E, Murphy L (2003) Putative functional characteristics of human estrogen receptor-beta isoforms. J Mol Endocrinol 30:13–29. doi:10.1677/jme.0.0300013

    Article  CAS  PubMed  Google Scholar 

  9. Roger P, Sahla M, Makela S, Gustafsson JA, Baldet P, Rochefort H (2001) Decreased expression of estrogen receptor beta protein in proliferative preinvasive mammary tumors. Cancer Res 61:2537–2541

    CAS  PubMed  Google Scholar 

  10. Dotzlaw H, Leygue E, Watson P, Murphy L (1999) Estrogen receptor-b messenger RNA expression in human breast tumor biopsies: relationship to steroid receptor status and regulation by progestins. Cancer Res 59:529–532

    CAS  PubMed  Google Scholar 

  11. Speirs V (2002) Oestrogen receptor beta in breast cancer: good bad or still too early to tell? J Pathol 197:143–147. doi:10.1002/path.1072

    Article  CAS  PubMed  Google Scholar 

  12. Fuqua S, Schiff R, Parra I, Friedrichs W, Su J, McKee D, Slentz-Kesler K, Moore L, Willson T, Moore J (1999) Expression of wild-type estrogen receptor beta and variant isoforms in human breast cancer. Cancer Res 59:5425–5428

    CAS  PubMed  Google Scholar 

  13. Saji S, Omoto Y, Shimizu C, Warner M, Hayashi Y, Horiguchi S, Watanabe T, Hayashi S, Gustafsson J (2002) Expression of estrogen receptor (ER) (beta)cx protein in ER(alpha)-positive breast cancer: specific correlation with progesterone receptor. Cancer Res 62:4849–4853

    CAS  PubMed  Google Scholar 

  14. Saji S, Omoto Y, Shimizu C, Horiguchi S, Watanabe T, Funata N, Hayash S, Gustafsson J, Toi M (2002) A Clinical impact of assay of estrogen receptor beta cx in breast cancer. Breast Cancer 9:303–307. doi:10.1007/BF02967608

    Article  PubMed  Google Scholar 

  15. Mann S, Laucirica R, Carlson N, Younes PS, Ali N, Younes A, Li Y, Younes M (2001) Estrogen receptor beta expression in invasive breast cancer. Hum Pathol 32(1):113–118. doi:10.1053/hupa.2001.21506

    Article  CAS  PubMed  Google Scholar 

  16. Murphy L, Cherlet T, Lewis A, Banu Y, Watson P (2003) New insights into estogen receptor function in human breast cancer. Ann Med 35:614–631. doi:10.1080/07853890310014579

    Article  CAS  PubMed  Google Scholar 

  17. Esslimani-Sahla M, Simony-Lafontaine J, Kramar A, Lavaill R, Mollevi C, Warner M, Gustafsson J-A, Rochefort H (2004) Estrogen receptor beta (ERbeta) level but not its ERbeta-cx variant helps to predict tamoxifen resistance in breast cancer. Clin Cancer Res 10:5769–5776. doi:10.1158/1078-0432.CCR-04-0389

    Article  CAS  PubMed  Google Scholar 

  18. Fleming F, Hill A, McDermott E, O’Higgins N, Young L (2004) Differential recruitment of coregulator proteins steroid receptor coactivator-1 and silencing mediator for retinoid and thyroid receptors to the estrogen receptorestrogen response element by beta-estradiol and 4-hydroxytamoxifen in human breast cancer. J Clin Endocrinol Metab 89:375–383. doi:10.1210/jc.2003-031048

    Article  CAS  PubMed  Google Scholar 

  19. Hopp TA, Weiss HL, Parra IS, Cui Y, Osborne CK, Fuqua SA (2004) Low levels of estrogen receptor beta protein predict resistance to tamoxifen therapy in breast cancer. Clin Cancer Res 10(22):7490–7499. doi:10.1158/1078-0432.CCR-04-1114

    Article  CAS  PubMed  Google Scholar 

  20. Skliris G, Munot K, Bell S, Carder P, Lane S, Horgan K, Lansdown M, Parkes A, Hanby A, Markham A, Speirs V (2003) Reduced expression of oestrogen receptor beta in invasive breast cancer and its re-expression using DNA methyltransferase inhibitors in a cell line model. J Pathol 201:213–220. doi:10.1002/path.1436

    Article  CAS  PubMed  Google Scholar 

  21. Treeck O, Juhasz-Boess I, Lattrich C, Horn F, Goerse R, Ortmann O (2008) Effects of exon-deleted estrogen receptor β transcript variants on growth, apoptosis and gene expression of human breast cancer cell lines. Breast Cancer Res Treat 110(3):507–520. doi:10.1007/s10549-007-9749-7

    Article  CAS  PubMed  Google Scholar 

  22. Paruthiyil S, Parmar H, Kerekatte V, Cunha GR, Firestone GL, Leitman DC (2004) Estrogen receptor beta inhibits human breast cancer cell proliferation and tumor formation by causing a G2 cell cycle arrest. Cancer Res 64(1):423–428. doi:10.1158/0008-5472.CAN-03-2446

    Article  CAS  PubMed  Google Scholar 

  23. Ståhlberg A, Åman P, Ridell B, Mostad P, Kubista M (2003) A quantitative real-time PCR method for detection of B-lymphocyte monoclonality by comparison of kappa and lambda immunoglobulin light chain expression. Clin Chem 49(1):51–59. doi:10.1373/49.1.51

    Article  PubMed  Google Scholar 

  24. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(−ΔΔCT) method. Methods 25(4):402–408. doi:10.1006/meth.2001.1262

    Article  CAS  PubMed  Google Scholar 

  25. Cheng J, Lee EJ, Madison LD, Lazennec G (2004) Expression of estrogen receptor beta in prostate carcinoma cells inhibits invasion and proliferation and triggers apoptosis. FEBS Lett 566(1–3):169–172. doi:10.1016/j.febslet.2004.04.025

    Article  PubMed  Google Scholar 

  26. Soule HD et al (1990) Isolation and characterization of a spontaneously immortalized human breast epithelial MCF- 10. Cancer Res 50:6075–6086

    CAS  PubMed  Google Scholar 

  27. Fuchs IB, Lichtenegger W, Buehler H, Henrich W, Stein H, Kleine-Tebbe A, Schaller G (2002) The prognostic significance of epithelial-mesenchymal transition in breast cancer. Anticancer Res 22(6A):3415–3419

    PubMed  Google Scholar 

  28. Bonin S, Brunetti D, Benedetti E, Dotti I, Gorji N, Stanta G (2008) Molecular characterisation of breast cancer patients at high and low recurrence risk. Virchows Arch 452(3):241–250. doi:10.1007/s00428-007-0570-9

    Article  CAS  PubMed  Google Scholar 

  29. Honma N, Horii R, Iwase T, Saji S, Younes M, Takubo K, Matsuura M, Ito Y, Akiyama F, Sakamoto G (2008) Clinical importance of estrogen receptor-beta evaluation in breast cancer patients treated with adjuvant tamoxifen therapy. J Clin Oncol 26(22):3727–3734. doi:10.1200/JCO.2007.14.2968

    Article  PubMed  Google Scholar 

  30. Hodges-Gallagher L, Valentine CD, El Bader S, Kushner PJ (2008) Estrogen receptor beta increases the efficacy of antiestrogens by effects on apoptosis and cell cycling in breast cancer cells. Breast Cancer Res Treat 109(2):241–250. doi:10.1007/s10549-007-9640-6

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

We thank Helena Houlihan and Gerhard Piendl for their excellent technical assistance.

Author information

Authors and Affiliations

  1. Department of Obstetrics and Gynecology, University of Regensburg, 93053, Regensburg, Germany

    Oliver Treeck, Claus Lattrich, Anette Springwald & Olaf Ortmann

  2. Lehrstuhl für Frauenheilkunde und Geburtshilfe der Universität Regensburg, Caritas Krankenhaus St. Josef, Landshuter Str. 65, 93053, Regensburg, Germany

    Oliver Treeck

Authors
  1. Oliver Treeck
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Claus Lattrich
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Anette Springwald
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Olaf Ortmann
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Oliver Treeck.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Treeck, O., Lattrich, C., Springwald, A. et al. Estrogen receptor beta exerts growth-inhibitory effects on human mammary epithelial cells. Breast Cancer Res Treat 120, 557–565 (2010). https://doi.org/10.1007/s10549-009-0413-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10549-009-0413-2

Keywords

Search

Navigation